Cell and Gene Therapy for Personalised Medicine (CGT4PM2027) - European Partnership for Personalised Medicine
European Commission · Horizon Europe Framework Programme (HORIZON) · cascade funding under HORIZON-HLTH-2023-CARE-08-01
Posted 4 Nov 2026 · About 3 months left
In plain terms
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.
Summary from the donor's own text; the full wording is below.
Summary
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.
At least one of the following approaches must be employed:
Somatic cell therapeutics;
Gene therapeutics;
Combined cell- and gene therapeutics;
Novel biological products.
For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.